Paul Joseph Dyson
Cited by
Cited by
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
CG Hartinger, PJ Dyson
Chemical Society Reviews 38 (2), 391-401, 2009
KP1019, a new redox‐active anticancer agent–Preclinical development and results of a clinical phase I study in tumor patients
CG Hartinger, MA Jakupec, S Zorbas‐Seifried, M Groessl, A Egger, ...
Chemistry & biodiversity 5 (10), 2140-2155, 2008
In vitro and in vivo evaluation of ruthenium (II)− arene PTA complexes
C Scolaro, A Bergamo, L Brescacin, R Delfino, M Cocchietto, G Laurenczy, ...
Journal of medicinal chemistry 48 (12), 4161-4171, 2005
Homogeneous catalysis for sustainable hydrogen storage in formic acid and alcohols
K Sordakis, C Tang, LK Vogt, H Junge, PJ Dyson, M Beller, G Laurenczy
Chemical reviews 118 (2), 372-433, 2018
Efficient dehydrogenation of formic acid using an iron catalyst
A Boddien, D Mellmann, F Gärtner, R Jackstell, H Junge, PJ Dyson, ...
Science 333 (6050), 1733-1736, 2011
Why are ionic liquids liquid? A simple explanation based on lattice and solvation energies
I Krossing, JM Slattery, C Daguenet, PJ Dyson, A Oleinikova, ...
Journal of the American Chemical Society 128 (41), 13427-13434, 2006
Ruthenium in medicine: current clinical uses and future prospects
CS Allardyce, PJ Dyson
Platinum Metals Review 45 (2), 62-69, 2001
A viable hydrogen-storage system based on selective formic acid decomposition with a ruthenium catalyst
C Fellay, PJ Dyson, G Laurenczy
Angewandte Chemie, International Edition 47 (21), 3966-8, 2008
Direct synthesis of formic acid from carbon dioxide by hydrogenation in acidic media
S Moret, PJ Dyson, G Laurenczy
Nature communications 5 (1), 4017, 2014
Selective degradation of wood lignin over noble‐metal catalysts in a two‐step process
N Yan, C Zhao, PJ Dyson, C Wang, L Liu, Y Kou
ChemSusChem: Chemistry & Sustainability Energy & Materials 1 (7), 626-629, 2008
Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes
X Zhang, L Meng, Q Lu, Z Fei, PJ Dyson
Biomaterials 30 (30), 6041-6047, 2009
Challenges and opportunities in the development of organometallic anticancer drugs
CG Hartinger, N Metzler-Nolte, PJ Dyson
Organometallics 31 (16), 5677-5685, 2012
Metal-based antitumour drugs in the post genomic era
PJ Dyson, G Sava
Dalton Transactions, 1929-1933, 2006
Classical and non‐classical ruthenium‐based anticancer drugs: Towards targeted chemotherapy
W Han Ang, PJ Dyson
European Journal of Inorganic Chemistry 2006 (20), 4003-4018, 2006
A well‐defined iron catalyst for the reduction of bicarbonates and carbon dioxide to formates, alkyl formates, and formamides
C Federsel, A Boddien, R Jackstell, R Jennerjahn, PJ Dyson, R Scopelliti, ...
Angewandte Chemie International Edition 50 (49), 9777-9780, 2010
From dysfunction to bis‐function: on the design and applications of functionalised ionic liquids
Z Fei, TJ Geldbach, D Zhao, PJ Dyson
Chemistry–A European Journal 12 (8), 2122-2130, 2006
The “Complex‐in‐a‐Complex” Cations [(acac)2M⊂Ru6(piPrC6H4Me)6(tpt)2(dhbq)3]6+: A Trojan Horse for Cancer Cells
B Therrien, G Süss‐Fink, P Govindaswamy, AK Renfrew, PJ Dyson
Angewandte Chemie 120 (20), 3833-3836, 2008
Nitrile-functionalized pyridinium ionic liquids: Synthesis, characterization, and their application in carbon− carbon coupling reactions
D Zhao, Z Fei, TJ Geldbach, R Scopelliti, PJ Dyson
Journal of the American Chemical Society 126 (48), 15876-15882, 2004
Ultrathin rhodium nanosheets
H Duan, N Yan, R Yu, CR Chang, G Zhou, HS Hu, H Rong, Z Niu, J Mao, ...
Nature communications 5 (1), 3093, 2014
The development of RAPTA compounds for the treatment of tumors
BS Murray, MV Babak, CG Hartinger, PJ Dyson
Coordination Chemistry Reviews 306, 86-114, 2016
The system can't perform the operation now. Try again later.
Articles 1–20